Cardiac and cancer testing help spur growth in immunodiagnostics market
This article was originally published in Clinica
Executive Summary
The global market for immunodiagnostic products totalled $7.0 billion in 2006. The largest segment was general-purpose immunoassay systems, totalling $5.0 billion including reagents, consumables, equipment and service. This segment includes both stand-alone immunoassay analysers as well as immunoassay tests performed on integrated chemistry/immunochemistry systems. The segment is forecast to grow at 7.9% per year on average over the 2006-2011 period. Factors responsible for growth in the general-purpose segment include the continued trend for specialty immunoassay tests to be converted to general-purpose testing platforms, strong growth in tests such as cardiac marker assays and infectious disease tests that are performed on general-purpose systems, and growth in adoption of integrated chemistry/routine immunochemistry testing platforms.